跳至主要内容
临床试验/DRKS00033174
DRKS00033174已完成不适用

se of bioreactance technology for early detection of reduced stroke volume during cesarean delivery under spinal anesthesia

niversitätsklinikum Marburg0 个研究点目标入组 60 人开始时间: 2023年12月6日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
Female

入选标准

  • Patients undergoing an elective caesarean delivery
  • - Spinal anaesthesia as an anaesthesia procedure for caesarean delivery
  • - Signed informed consent for inclusion in this study

排除标准

  • - Patients < 18 years of age
  • - No SPA, but primarily general anaesthesia as the anaesthetic procedure for the caesarean section
  • - Patients who do not wish to participate in the examination (i.e. there is no signed consent form)
  • - Patients in whom the placement of the four adhesive electrodes is not possible for medical reasons (e.g. extensive wound or skin rash in the target area)
  • - Contraindications according to the manufacturer of the Starling monitor (Baxter)
  • - Presence of severe (clinically relevant) aortic valve insufficiency
  • - Severe anatomical anomalies of the thoracic aorta, e.g. (large) synthetic aortic grafts
  • - external / internal pacemakers with unipolar electrodes

研究者

发起方
niversitätsklinikum Marburg

相似试验